Millennium Laboratories v. Ward

CourtNebraska Supreme Court
DecidedDecember 19, 2014
DocketS-13-286
StatusPublished

This text of Millennium Laboratories v. Ward (Millennium Laboratories v. Ward) is published on Counsel Stack Legal Research, covering Nebraska Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Millennium Laboratories v. Ward, (Neb. 2014).

Opinion

Nebraska Advance Sheets 718 289 NEBRASKA REPORTS

Millennium Laboratories, Inc., et al., appellants, v. Brian Ward, an individual, appellee. ___ N.W.2d ___

Filed December 19, 2014. No. S-13-826.

1. Res Judicata: Appeal and Error. The applicability of the doctrine of res judi- cata is a question of law, as to which an appellate court is obligated to reach a conclusion independent of the determination reached by the court below. 2. Res Judicata: Collateral Estoppel. The applicability of claim and issue preclu- sion is a question of law. 3. Pleadings: Appeal and Error. An appellate court reviews de novo a lower court’s dismissal of a complaint for failure to state a claim. 4. Jurisdiction: Appeal and Error. Generally, once an appeal has been perfected, the trial court no longer has jurisdiction. 5. Res Judicata: Judgments. The doctrine of res judicata provides that a final judgment on the merits of an action precludes the parties or their privies from relitigating issues that were or could have been raised in that action. 6. Res Judicata. For res judicata to apply, there must be (1) a final judgment on the merits that is, (2) based on proper jurisdiction, (3) between the same parties or their privies, and (4) based on the same claims or causes of action. 7. Appeal and Error. An appellate court is not obligated to engage in an analysis that is not necessary to adjudicate the case and controversy before it.

Appeal from the District Court for Sarpy County: William B. Zastera, Judge. Reversed and remanded for further proceedings. James P. Fitzgerald and Patrick E. Brookhouser, Jr., of McGrath, North, Mullin & Kratz, P.C., L.L.O., and Lance A. Etcheverry and Jessica N. Walker, of Skadden, Arps, Slate, Meagher & Flom, L.L.P., for appellants. Michael T. Hilgers and Carrie S. Dolton, of Gober Hilgers, P.L.L.C., and Heather A. Boice and Michael R. Osterhoff, of Perkins Coie, L.L.P., for appellee. Heavican, C.J., Wright, Connolly, Stephan, McCormack, Miller-Lerman, and Cassel, JJ. Wright, J. I. NATURE OF CASE In 2013, as part of ongoing litigation between Ameritox, Ltd., and Millennium Laboratories, Inc. (Millennium), a U.S. district court in Florida (Florida court) denied Millennium’s Nebraska Advance Sheets MILLENNIUM LABORATORIES v. WARD 719 Cite as 289 Neb. 718

motion for leave to amend its second amended counter- claims to Ameritox’s third amended complaint. Subsequently, Millennium and two of its employees sued Brian Ward, one of Ameritox’s employees, in the district court for Sarpy County, Nebraska (district court). Ward moved to dismiss for failure to state a claim. He specifically alleged that the complaint against him was barred under the doctrine of res judicata, or claim preclusion. The district court determined that the Florida court’s denial of Millennium’s motion to amend its counterclaims barred the claims against Ward filed in Nebraska and sustained Ward’s motion to dismiss. Because we find that the district court erred in concluding that the Florida court’s order denying leave to amend barred the action against Ward, we reverse the judgment of the district court and remand the cause for fur- ther proceedings.

II. SCOPE OF REVIEW [1] The applicability of the doctrine of res judicata is a question of law, as to which we are obligated to reach a conclusion independent of the determination reached by the court below. In re Interest of D.H., 281 Neb. 554, 797 N.W.2d 263 (2011). [2] The applicability of claim and issue preclusion is a question of law. Hara v. Reichert, 287 Neb. 577, 843 N.W.2d 812 (2014). [3] An appellate court reviews de novo a lower court’s dis- missal of a complaint for failure to state a claim. Doe v. Omaha Pub. Sch. Dist., 273 Neb. 79, 727 N.W.2d 447 (2007).

III. FACTS 1. Parties Millennium is a California corporation with its principal place of business in that state. It provides urine and saliva testing services to physicians and other health care profes- sionals. Amos Burdine and Jackson Benefield are employed as sales representatives for Millennium in Nebraska and Iowa. Burdine and Benefield are residents of Nebraska and Iowa, respectively. Nebraska Advance Sheets 720 289 NEBRASKA REPORTS

Ameritox provides similar services and is in direct compe- tition with Millennium. Ameritox is a Texas limited partner- ship with its principal place of business in Maryland. Ward, a Nebraska resident, is employed as a sales representative for Ameritox in Nebraska.

2. Florida Litigation In 2011, Ameritox sued Millennium in the Florida court. The record does not tell us the nature of Ameritox’s claims against Millennium. In August 2012, Millennium filed its sec- ond amended counterclaims in response to Ameritox’s third amended complaint. Millennium raised counterclaims under state unfair trade practices laws in Florida, California, Texas, and New York; common-law unfair competition; and common- law tortious interference with business relationships. As part of its counterclaims, Millennium alleged that Ameritox had “engaged in unlawful schemes designed to main- tain and enlarge its business . . . at the expense of Millennium and the American public.” It alleged that Ameritox did the fol- lowing to gain customers and increase its sales: • Encouraged health care providers using Ameritox’s serv­ ices to order medically unnecessary tests and panels of tests rather than individual tests so as to maximize insur- ance payments; • Placed Ameritox employees in the offices of health care providers as specimen collectors or processors on the condi- tion that the health care providers would submit a certain number of tests to Ameritox; and • Offered improper financial inducements and kickbacks in exchange for referrals. After the Florida court’s deadline for amending pleadings, Millennium moved for leave to amend its second amended counterclaims to Ameritox’s third amended complaint. Millennium’s proposed third amended counterclaims alleged that Ameritox engaged in deceptive trade practices through the same general conduct alleged in Millennium’s second amended counterclaims. The proposed third amended coun- terclaims added allegations that Ameritox disseminated false and misleading statements to “health care providers across Nebraska Advance Sheets MILLENNIUM LABORATORIES v. WARD 721 Cite as 289 Neb. 718

the country” on the subjects of (1) the federal investigation of Millennium in Massachusetts, (2) the legality of Ameritox’s kickbacks and financial inducements, (3) the propriety of mak- ing testing recommendations based on insurance coverage, and (4) the in-network status of insurance providers. As “proof of Ameritox’s false and misleading statements,” Millennium’s proposed third amended counterclaims described actions taken by Ward: In or around November 2012, . . . Ward, an Ameritox sales representative in Nebraska and Iowa (among other states), visited a Millennium customer located in Iowa, and sought to convince it to stop doing business with Millennium and to refer future business to Ameritox. In making his sales pitch, Ward provided Millennium’s customer with . . . a document that made a series of false and misleading statements about the Massachusetts Investigation. .... . . . Ameritox has widely disseminated the forego- ing false and misleading representations, and statements similar to them, to a substantial portion of health care providers nationwide. The proposed third amended counterclaims described one other example of the ways in which Ameritox disseminated false information about Millennium, but this second example did not involve Ward. Based on these new factual allegations, Millennium pro- posed to add a counterclaim against Ameritox under the Lanham Act, 15 U.S.C. § 1051

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Millennium Laboratories v. Ward, Counsel Stack Legal Research, https://law.counselstack.com/opinion/millennium-laboratories-v-ward-neb-2014.